Medicated IUS
Description: An intrauterine system (IUS) containing a progestin - likely etonogestrel.
Product Details
Dose: 38mg, 61mg or 72mg
Active Pharmaceutical Ingredient (API):
Status Details
Status Details: - Phase II studies were completed in July 2011 to test different quantities of etonogestrel (38mg, 61mg, 72mg) and different thicknesses of the reservoir's membrane (350 μm, 140 μm, and 50 μm), respectively. This work was done under authority of the European Medicines Agency.
- Phase II studies were completed in July 2011 to test different quantities of etonogestrel (38mg, 61mg, 72mg) and different thicknesses of the reservoir's membrane (350 μm, 140 μm, and 50 μm), respectively. This work was done under authority of the European Medicines Agency.
Additional Information
References: Clinical trials report: https://clinicaltrials.gov/ct2/show/NCT00967746?term=intrauterine+and+me...
Clinical trials report: https://clinicaltrials.gov/ct2/show/NCT00967746?term=intrauterine+and+me...